High-affinity interactions between peptides and heat shock protein 70 augment CD8+ T lymphocyte immune responses

Journal of Immunology

Volumn 177, Issue 2, 2006, Pages 1017-1027

  Flechtner, Jessica B ^a   Cohane, Kenya Prince ^a   Mehta, Sunil ^a,b   Slusarewicz, Paul ^a,c   Leonard, Alexis Kays ^a,d   Barber, Brian H ^a,e   Levey, Daniel L ^a   Andjelic, Sofija ^a,f  

^a Antigenics Inc   (United States)

^b CENTOCOR INC   (United States)

^c DFB Pharmaceuticals   (United States)

^d Nastech Pharmaceutical Company Inc   (United States)

^e UNIVERSITY HEALTH NETWORK   (Canada)

^f A Subsidiary of Lantheus Holdings   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLLEUCYLPHENYLALANYLASPARTYLISOLEUCYLGLUTAMYLSERYLLYSYLVALYLGLYCYLSERYL GLYCYLHISTIDYLTRYPTOPHYLASPARTYLPHENYLALANYLALANYLTRYPTOPHYLPROLYLTRYPTOPHAN; EPITOPE; FLUORESCEIN; HEAT SHOCK PROTEIN 70; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; OVALBUMIN; PEPTIDE; SERYLISOLEUCYLISOLEUCYLARGINYLPHENYLALANYLGLUTAMYLLYSYLLEUCINE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CD8+ T LYMPHOCYTE; COMPETITIVE BINDING ASSAY; COMPLEX FORMATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISSOCIATION CONSTANT; FEMALE; IMMUNOGENICITY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

EID: 33745831228     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.2.1017     Document Type: Article

References (60)

1. Chappell, T. G., B. B. Konforti, S. L. Schmid, and J. E. Rothman. 1987. The ATPase core of a clathrin uncoating protein. J. Biol. Chem. 262: 746-751.
2. Flynn, G. C., T. G. Chappell, and J. E. Rothman. 1989. Peptide binding and release by proteins implicated as catalysts of protein assembly. Science 245: 385-390.
3. Basu, S., R. J. Binder, R. Suto, K. M. Anderson, and P. K. Srivastava. 2000. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway. Int. Immunol. 12: 1539-1546.
4. Singh-Jasuja, H., H. U. Scherer, N. Hilf, D. Arnold-Schild, H. G. Rammensee, R. E. Toes, and H. Schild. 2000. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur. J. Immunol. 30: 2211-2215.
5. Flohe, S. B., J. Bruggemann, S. Lendemans, M. Nikulina, G. Meierhoff, S. Flohe, and H. Kolb. 2003. Human heat shock protein 60 induces maturation of dendritic cells versus a Th1-promoting phenotype. J. Immunol. 170: 2340-2348.
6. Wang, Y., T. Whittall, E. McGowan, J. Younson, C. Kelly, L. A. Bergmeier, M. Singh, and T. Lehner. 2005. Identification of stimulating and inhibitory epitopes within the heat shock protein 70 molecule that modulate cytokine production and maturation of dendritic cells. J. Immunol. 174: 3306-3316.
7. Wang, Y., C. G. Kelly, M. Singh, E. G. McGowan, A. S. Carrara, L. A. Bergmeier, and T. Lehner. 2002. Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J. Immunol. 169: 2422-2429.
8. Wan, T., X. Zhou, G. Chen, H. An, T. Chen, W. Zhang, S. Liu, Y. Jiang, F. Yang, Y. Wu, and X. Cao. 2003. Novel heat shock protein Hsp70L1 activates dendritic cells and acts as a Th1 polarizing adjuvant. Blood 103: 1747-1754.
9. Panjwani, N. N., L. Popova, and P. K. Srivastava. 2002. Heat shock proteins gp96 and hsp70 activate the release of nitric oxide by APCs. J. Immunol. 168: 2997-3003.
10. Srivastava, P. K., and H. Udono. 1994. Heat shock protein-peptide complexes in cancer immunotherapy. Curr. Opin. Immunol. 6: 728-732.
11. Srivastava, P. K., A. B. DeLeo, and L. J. Old. 1986. Tumor rejection antigens of chemically induced sarcomas of inbred mice. Proc. Natl. Acad. Sci. USA 83: 3407-3411.
12. Udono, H., and P. K. Srivastava. 1993. Heat shock protein 70-associated peptides elicit specific cancer immunity. J. Exp. Med. 178: 1391.
13. + T cells in vivo. Proc. Natl. Acad. Sci. USA 91: 3077-3081.
14. Li, Z., and P. K. Srivastava. 1993. Tumor rejection antigen gp96/grp94 is an ATPase: implications for protein folding and antigen presentation. EMBO J. 12: 3143-3151.
15. Sato, K., Y. Torimoto, Y. Tamura, M. Shindo, H. Shinzaki, K. Hirai, and Y. Kongo. 2001. Immunotherapy using heat-shock protein preparations of leukemia cells after syngeneic bone marrow transplantation in mice. Blood 98: 1852-1857.
16. Zugel, U., A. M. Sponaas, J. Neckermann, B. Schoel, and S. H. Kaufmann. 2001. gp96-peptide vaccination of mice against intracellular bacteria. Infect. Immun. 69: 4164-4167.
17. + T cells. Nat. Immunol. 6: 593-599.
18. Blachere, N. E., Z. Li, R. Y. Chandawarkar, R. Suto, N. S. Jaikaria, S. Basu, H. Udono, and P. K. Srivastava. 1997. Heat shock protein-peptide complexes, reconstituted in vitro, elicit peptide-specific cytotoxic T lymphocyte response and tumor immunity. J. Exp. Med. 186: 1315-1322.
19. Ciupitu, A. M., M. Petersson, C. L. O'Donnell, K. Williams, S. Jindal, R. Kiessling, and R. M. Welsh. 1998. Immunization with a lymphocytic choriomeningitis virus peptide mixed with heat shock protein 70 results in protective antiviral immunity and specific cytotoxic T lymphocytes. J. Exp. Med. 187: 685-691.
20. Navaratnam, M., M. S. Deshpande, M. J. Hariharan, D. S. Zatechka, Jr., and S. Srikumaran. 2001. Heat shock protein-peptide complexes elicit cytotoxic T-lymphocyte and antibody responses specific for bovine herpesvirus 1. Vaccine 19: 1425-1434.
21. Castellino, F., P. E. Boucher, K. Eichelberg, M. Mayhew, J. E. Rothman, A. N. Houghton, and R. N. Germain. 2000. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J. Exp. Med. 191: 1957-1964.
22. Sondermann, H., T. Becker, M. Mayhew, F. Wieland, and F. U. Hartl. 2000. Characterization of a receptor for heat shock protein 70 on macrophages and monocytes. Biol. Chem. 381: 1165-1174.
23. Wang, Y., C. G. Kelly, J. T. Karttunen, T. Whittall, P. J. Lehner, L. Duncan, P. MacAry, J. S. Younson, M. Singh, W. Oehlmann, et al. 2001. CD40 is a cellular receptor mediating mycobacterial heat shock protein 70 stimulation of CC-chemokines. Immunity 15: 971-983.
24. Basu, S., R. J. Binder, T. Ramalingam, and P. K. Srivastava. 2001. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14: 303-313.
25. Vabulas, R. M., P. Ahmad-Nejad, S. Ghose, C. J. Kirschning, R. D. Issels, and H. Wagner. 2002. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277: 15107-15112.
26. Asea, A., S. K. Kraeft, E. A. Kurt-Jones, M. A. Stevenson, L. B. Chen, R. W. Finberg, G. C. Koo, and S. K. Calderwood. 2000. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6: 435-442.
27. Asea, A., M. Rehli, E. Kabingu, J. A. Boch, O. Bare, P. E. Auron, M. A. Stevenson, and S. K. Calderwood. 2002. Novel signal transduction pathway utilized by extracellular HSP70: role of Toll-like receptor (TLR) 2 and TLR4. J. Biol. Chem. 277: 15028-15304.
28. Delneste, Y., G. Magistrelli, J. Gauchat, J. Haeuw, J. Aubry, K. Nakamura, N. Kawakami-Honda, L. Goetsch, T. Sawamura, J. Bonnefoy, and P. Jeannin. 2002. Involvement of LOX-1 in dendritic cell-mediated antigen cross-presentation. Immunity 17: 353-362.
29. Berwin, B., J. P. Hart, S. Rice, C. Gass, S. V. Pizzo, S. R. Post, and C. V. Nicchitta. 2003. Scavenger receptor-A mediates gp96/GRP94 and calreticulin internalization by antigen-presenting cells. EMBO J. 22: 6127-6136.
30. Berwin, B., Y. Delneste, R. V. Lovingood, S. R. Post, and S. V. Pizzo. 2004. SREC-I, a type F scavenger receptor, is an endocytic receptor for calreticulin. J. Biol. Chem. 279: 51250-51257.
31. Becker, T., F. U. Hartl, and F. Wieland. 2002. CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J. Cell Biol. 158: 1277-1285.
32. Binder, R. J., R. Vatner, and P. Srivastava. 2004. The heat-shock protein receptors: some answers and more questions. Tissue Antigens 64: 442-451.
33. Flynn, G. C., J. Pohl, M. T. Flocco, and J. E. Rothman. 1991. Peptide-binding specificity of the molecular chaperone BiP. Nature 353: 726-730.
34. Moroi, Y., M. Mayhew, J. Trcka, M. H. Hoe, Y. Takechi, F. U. Hartl, J. E. Rothman, and A. N. Houghton. 2000. Induction of cellular immunity by immunization with novel hybrid peptides complexed to heat shock protein 70. Proc. Natl. Acad. Sci. USA 97: 3485-3490.
35. + T lymphocytes from β2 microglobulin (β2m) HLA-A2.1 monochain transgenic H-2Db β2m double knockout mice. J. Exp. Med. 185: 2043-2051.
36. Blond-Elguindi, S., S. E. Cwirla, W. J. Dower, R. J. Lipshutz, S. R. Sprang, J. F. Sambrook, and M. J. Gething. 1993. Affinity panning of a library of peptides displayed on bacteriophages reveals the binding specificity of BiP. Cell 75: 717-728.
37. Gragerov, A., and M. E. Gottesman. 1994. Different peptide binding specificities of hsp70 family members. J. Mol. Biol. 241: 133-135.
38. Gragerov, A., L. Zeng, X. Zhao, W. Burkholder, and M. E. Gottesman. 1994. Specificity of DnaK-peptide binding. J. Mol. Biol. 235: 848-854.
39. Takenaka, I. M., S. M. Leung, S. J. McAndrew, J. P. Brown, and L. E. Hightower. 1995. Hsc70-binding peptides selected from a phage display peptide library that resemble organellar targeting sequences. J. Biol. Chem. 270: 19839-19844.
40. MacAry, P. A., B. Javid, R. A. Floto, K. G. Smith, W. Oehlmann, M. Singh, and P. J. Lehner. 2004. HSP70 peptide binding mutants separate antigen delivery from dendritic cell stimulation. Immunity 20: 95-106.
41. Ackerman, A. L., and P. Cresswell. 2004. Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5: 678-684.
42. Kamboj, R. C., S. Pal, N. Raghav, and H. Singh. 1993. A selective colorimetric assay for cathepsin L using Z-Phe-Arg-4-methoxy-β- naphthylamide. Biochimie 75: 873-878.
43. Higaki, J., R. Catalano, A. W. Guzzetta, D. Quon, J. F. Nave, C. Tarnus, H. D'Orchymont, and B. Cordell. 1996. Processing of β-amyloid precursor protein by cathepsin D. J. Biol. Chem. 271: 31885-31893.
44. Kuttler, C., A. K. Nussbaum, T. P. Dick, H. G. Rammensee, H. Schild, and K. P. Hadeler. 2000. An algorithm for the prediction of proteasomal cleavages. J. Mol. Biol. 298: 417-429.
45. Schwarz, G., W. H. Boehncke, M. Braun, C. J. Schroter, T. Burster, T. Flad, D. Dressel, E. Weber, H. Schmid, and H. Kalbacher. 2002. Cathepsin S activity is detectable in human keratinocytes and is selectively upregulated upon stimulation with interferon-γ. J. Invest. Dermatol. 119: 44-49.
46. Arnold, D., S. Faath, H. Rammensee, and H. Schild. 1995. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J. Exp. Med. 182: 885-889.
47. Brenner, B. G., and M. A. Wainberg. 1999. Heat shock protein-based therapeutic strategies against human immunodeficiency virus type 1 infection. Infect. Dis. Obstet. Gynecol. 7: 80-90.
48. Gupta, R. K., E. H. Relyveld, E. B. Lindblad, B. Bizzini, S. Ben-Efraim, and C. K. Gupta. 1993. Adjuvants-a balance between toxicity and adjuvanticity. Vaccine 11: 293-306.
49. Slepenkov, S. V., and S. N. Witt. 2003. Detection of a concerted conformational change in the ATPase domain of DnaK triggered by peptide binding. FEBS Lett. 539: 100-104.
50. Stevens, S. Y., S. Cai, M. Pellecchia, and E. R. Zuiderweg. 2003. The solution structure of the bacterial HSP70 chaperone protein domain DnaK(393-507) in complex with the peptide NRLLLTG. Protein Sci. 12: 2588-2596.
51. Reits, E., A. Griekspoor, J. Neijssen, T. Groothuis, K. Jalink, P. van Veelen, H. Janssen, J. Calafat, J. W. Drijfhout, and J. Neefjes. 2003. Peptide diffusion, protection, and degradation in nuclear and cytoplasmic compartments before antigen presentation by MHC class I. Immunity 18: 97-108.
52. York, I. A., A. L. Goldberg, X. Y. Mo, and K. L. Rock. 1999. Proteolysis and class I major histocompatibility complex antigen presentation. Immunol. Rev. 172: 49-66.
53. Wang, R.-F., E. Appella, Y. Kawakami, X. Kang, and S. A. Rosenberg. 1996. Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J. Exp. Med. 184: 2207-2216.
54. + T cells by a single amino acid-substituted peptide derived from bovine αs1-casein. Clin. Immunol. Immunopathol. 88: 277-286.
55. Kast, W. M., L. Roux, J. Curren, H. J. Blom, A. C. Voordouw, R. H. Meloen, D. Kolakofsky, and C. J. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus-specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA 88: 2283-2287.
56. Van Bleek, G. M., and S. G. Nathenson. 1990. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature 348: 213-216.
57. Skipper, J. C., R. C. Hendrickson, P. H. Gulden, V. Brichard, A. Van Pel, Y. Chen, J. Shabanowitz, T. Wolfel, C. L. Slingluff, Jr., T. Boon, et al. 1996. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J. Exp. Med. 183: 527-534.
58. Parkhurst, M. R., M. L. Salgaller, S. Southwood, P. F. Robbins, A. Sette, S. A. Rosenberg, and Y. Kawakami. 1996. Improved induction of melanoma-reactive CTL with peptides from the melanoma antigen gp100 modified at HLA-A*0201-binding residues. J. Immunol. 157: 2539-2548.
59. Parkhurst, M. R., E. B. Fitzgerald, S. Southwood, A. Sette, S. A. Rosenberg, and Y. Kawakami. 1998. Identification of a shared HLA-A*0201-restricted T-cell epitope from the melanoma antigen tyrosinase-related protein 2 (TRP2). Cancer Res. 58: 4895-4901.
60. Kawakami, Y., S. Eliyahu, K. Sakaguchi, P. F. Robbins, L. Rivoltini, J. R. Yannelli, E. Appella, and S. A. Rosenberg. 1994. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med. 180: 347-352.